Delivering measurable results across biologics, cell therapy, gene therapy, and combination products.
Rapid scale-up of a monoclonal antibody from lab to clinical production.
Robust upstream and downstream process optimization with analytical validation.
Startup required GMP manufacturing for autologous cell therapy.
Closed-system process with full traceability and validated cryopreservation.
Scalable AAV vector production required.
Optimized production & purification process.
Injectable device for biologic delivery.
Integrated formulation with full validation.